THE LADY DAVIS Institute (LDI) of the Jewish General Hospital in Canada has congratulated Dr. Mark Wainberg, its former director, for his election as a Fellow of the American Association for the Advancement of Science (AAAS). According to Alan Leshner, CEO of the AAAS and Executive Publisher of the prestigious journal, “Science”, Dr. Wainberg is being recognised “for distinguished contributions to HIV drug development and studies of drug resistance, and for striving to make HIV drug access a reality for all.”
Dr. Wainberg is an internationally-renowned scientist who is probably best known for identifying 3TC as an effective anti-viral drug against HIV. He is responsible for numerous advances in drug development, and for countering drug resistance in the Human Immunodeficiency Virus (HIV). He has championed accessibility to treatment in impoverished regions of the world, where AIDS infection rates have been particularly devastating. His current research focuses on novel concepts for preventing the transmission of HIV.
“We are very proud to have Mark as a member of the LDI,” said Dr. Roderick McInnes, Director of the LDI. “Becoming a Fellow of the AAAS is very powerful recognition at the highest levels of the scientific profession.”
Distinguished
Dr. Wainberg is a member of numerous international advisory committees in the field of AIDS. Among other distinctions, he is a fellow of the Royal Society of Canada; an Officer of the Order of Canada; an Officer of the Order National du Québec; an Honorary Fellow of the Royal College of Physicians and Surgeons of Canada; and a Chevalier in the Legion d’ Honneur of France. In addition to the research he conducts at the LDI, he is Director of the McGill AIDS Centre, and is a Professor of Medicine, Microbiology and Immunology at McGill University.
Dr. Wainberg was scheduled to be formally recognized at the AAAS Fellows Forum on February 18, 2012 at the Association’s annual meeting in Vancouver.
The American Association for the Advancement of Science (AAAS) is the world’s largest general scientific society. Founded in 1848, it includes 262 affiliated societies and academies of science, serving 10 million individuals. Its flagship publication, “Science”, has the largest paid circulation of any peer-reviewed general science journal in the world, with an estimated total readership of one million. (News from the Jewish General Hospital in Canada)